Cooperative Agreement U2CDK143943
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $488,592 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support a TL1 training program for predoctoral students, postdoctoral physician-scientists, and postdoctoral PhD scientists pursuing research-focused careers in adult and pediatric nephrologic, urologic, and hematologic health and disease. The program identifies and recruits...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $623,607 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on August 1, 2026. The award funds research examining how impaired double-stranded DNA repair induces podocyte senescence and contributes to chronic kidney disease progression. The project integrates advanced genetic models, including podocyte-specific SETD1A knockout mice that develop focal segmental...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $839,770 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support cognitive and behavioral approaches to reduce binge eating and excess weight in adolescents. The award is a Project Grant with a period of performance extending through February 28, 2031, and work is performed in New Haven, Connecticut. The program promotes extramural basic...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $126,000 on August 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to identify vascular biomarkers and tissue signatures that predict cardiovascular risk in kidney transplant recipients. The project investigates whether early vascular biomarker trajectories and tissue expression patterns identify kidney transplant recipients at highest risk of...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $249,999 on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate transcriptional dysregulation mechanisms in SF3B1-mutant myelodysplastic syndromes. The research focuses on defining the role of HTATSF1, a protein involved in both splicing and transcription, in transcriptional dysregulation in splicing-factor-mutant myelodysplastic...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University School of Medicine $877,742 on September 2, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to evaluate the effect of a state-wide centralized patient coaching program about live donor kidney transplantation. The award funds the Live Donor Champion (LDC) program, which educates end-stage kidney disease patients, their caregivers, and social...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University $106,228 on September 30, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to generate functional parathyroid-like cells from human induced pluripotent stem cells through directed differentiation. The project seeks to develop stem cell-derived parathyroid cells as a potentially curative treatment for hypoparathyroidism, a debilitating condition arising...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Tulane University $1,226,298 on September 24, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate epigenetic control of nephron progenitor cell lifespan in mice and humans. The research addresses the cessation of nephrogenesis at birth, which eliminates the opportunity to generate new nephrons following congenital or acquired loss of renal mass. The project...
- Federal Grant Award Summary Yale University received a $133,333 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with completion targeted for August 31, 2026. The award funds research aimed at correcting the myeloid bias of aged hematopoietic stem and progenitor cells (HSPCs) by preventing linker histone turnover,...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University $872,273 on August 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to identify modifiable process delays in deceased donor kidney allocation through process mining analysis. The project applies process mining methodology to discover actual kidney placement workflows from data logs at multiple organ procurement organizations (OPOs). The research...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded Yale University a cooperative agreement for $195,437 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds the Connecticut Kidney, Urology, and Hematology Research Training (CKRT) Program, a TL1 training initiative that develops predoctoral and postdoctoral scientists for research careers in nephrology, urology, and classical hematology at Yale and UConn Health. Trainees selected on the basis of scientific merit and research potential will receive paired primary research mentors and dedicated mentoring teams. The program delivers a structured curriculum including didactics and hands-on training in grant writing, clinical trial design, statistics and computational science, presentations, and team science. Appointed trainees will participate in an annual retreat to support scientific exchange and communication of research findings to scientific and public audiences. The program will employ logic model-based evaluation to systematically assess trainee performance and satisfaction, track outcomes following completion, and refine program operations. Current and former trainees will serve on an internal advisory committee. Performance occurs in New Haven, Connecticut. The period of performance extends from September 1, 2026, through May 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $195.4k | 8/10/26 |